Private Label CBD Gummies Market Set to Reach $1.38 Billion by 2036 as Wellness Brands Embrace Outsourced Production

The private label CBD gummies market is projected to grow from $646.2 million in 2026 to $1,382.2 million by 2036 at a CAGR of 7.9%, driven by wellness brands seeking faster, lower-risk market entry through white-label manufacturing and direct-to-consumer sales channels.

Chicago Metrowire Staff
Business
Private Label CBD Gummies Market Set to Reach $1.38 Billion by 2036 as Wellness Brands Embrace Outsourced Production

The private label CBD gummies market is poised for significant expansion, with a projected value of $1,382.2 million by 2036, according to a report by Future Market Insights (FMI). Valued at $598.9 million in 2025 and $646.2 million in 2026, the market is expected to grow at a compound annual growth rate (CAGR) of 7.9% from 2026 to 2036. This growth is fueled by a rising preference among wellness brands for outsourced manufacturing, which reduces capital investment and accelerates product launches.

As competition intensifies in the functional wellness industry, companies are increasingly turning to private label CBD gummies to enter the market without investing in extraction facilities or confectionery manufacturing infrastructure. Retailers and regulators are placing greater emphasis on batch testing, ingredient traceability, and labeling accuracy, which encourages manufacturers to strengthen quality assurance. White label gummies dominate the service model segment, accounting for 46.2% of global demand in 2026, due to shorter commercialization timelines and lower formulation costs.

Broad-spectrum CBD gummies lead the spectrum segment with a 42.8% market share in 2026, driven by consumer preference for THC-free wellness products that retain multiple cannabinoids. Brand websites are the leading sales channel, representing 39.6% of demand, as they offer greater control over customer education and subscription programs. The United States is the fastest-growing country, with a CAGR of 8.5% through 2036, supported by a strong direct-to-consumer infrastructure and a robust wellness startup ecosystem.

Key drivers include the growing demand for outsourced manufacturing and faster product commercialization. However, regulatory complexity surrounding CBD health claims and labeling requirements poses restraints. Trends include investment in white-label solutions, broad-spectrum formulations, third-party testing, and sustainable packaging. Major players in the market include CBD Nationwide, Extract Labs, cbdMD, Inc., Charlotte's Web Holdings, Inc., and CV Sciences, Inc., among others. For detailed insights, access the full report at https://www.futuremarketinsights.com/reports/sample/rep-gb-33370.

Blockchain Registration

QR Code for Blockchain Registration